Michael Cloonan, Chief Business Officer at Sage Therapeutics, Inc. (SAGE), sold 25,000 shares at $175.00 ($4.4M) on 2019-05-22, disclosed to the SEC on 2019-05-24.
Open-market sale of $4.4M SAGE by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SION | SELL | 2025-09-30 | $1.5M | — | Filing → |
| SION | SELL | 2025-08-28 | $1.2M | — | Filing → |
| SION | SELL | 2025-08-21 | $569K | — | Filing → |